메뉴 건너뛰기




Volumn 68, Issue 2, 2007, Pages 96-102

Raised homocystein plasma concentration in patients with heart failure: Clinical significance;Elevate concentrazioni plasmatiche di omocisteina in pazienti affetti da insufficienza cardiaca: Significato clinico

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HOMOCYSTEINE; TRIACYLGLYCEROL;

EID: 34548346919     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: 10.4081/monaldi.2007.458     Document Type: Article
Times cited : (5)

References (37)
  • 1
    • 0014545138 scopus 로고
    • Vascular pathology of homocysteinemia: Implication for the pathogenesis of atherosclerosis
    • Mc Cully KS. Vascular pathology of homocysteinemia: implication for the pathogenesis of atherosclerosis. American J Pathology 1969, 56: 111-128.
    • (1969) American J Pathology , vol.56 , pp. 111-128
    • Mc Cully, K.S.1
  • 2
    • 0028788020 scopus 로고
    • Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteiene study
    • Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteiene study. Journal of American Medical Association 1995; 274: 1526-1533.
    • (1995) Journal of American Medical Association , vol.274 , pp. 1526-1533
    • Nygard, O.1    Vollset, S.E.2    Refsum, H.3
  • 3
    • 0029066299 scopus 로고
    • A quantitative assessment of plasma homocysteine as a risk factor for cardiovascular disease. Probable benefits of increasing folic and intakes
    • Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for cardiovascular disease. Probable benefits of increasing folic and intakes. Journal of American Medical Association 1995; 274: 1049-1057.
    • (1995) Journal of American Medical Association , vol.274 , pp. 1049-1057
    • Boushey, C.J.1    Beresford, S.A.2    Omenn, G.S.3    Motulsky, A.G.4
  • 4
    • 0021752123 scopus 로고
    • Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease
    • Brattstrom L, Hardebo JE, Hultberg BJ. Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984; 15: 1012-1016.
    • (1984) Stroke , vol.15 , pp. 1012-1016
    • Brattstrom, L.1    Hardebo, J.E.2    Hultberg, B.J.3
  • 5
    • 0028966321 scopus 로고
    • Association between plasma homocysteine concentrations and extracranial carotid artery stenosis
    • Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. New England Journal of Medicine 1995; 332: 286-291.
    • (1995) New England Journal of Medicine , vol.332 , pp. 286-291
    • Selhub, J.1    Jacques, P.F.2    Bostom, A.G.3
  • 6
    • 0025756673 scopus 로고
    • Hyperhomocysteinemia as an indipendent risk factor for vascular disease
    • Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia as an indipendent risk factor for vascular disease. New England Journal of Medicine 1991, 1149-1155.
    • (1991) New England Journal of Medicine , pp. 1149-1155
    • Clarke, R.1    Daly, L.2    Robinson, K.3
  • 7
    • 0026684554 scopus 로고    scopus 로고
    • Stampfer M, et al. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of plasma homocysteine and risk of myocardial infarction in U.S. phisicians. Journal of American Medical Association 1992, 268: 877-881.
    • Stampfer M, et al. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of plasma homocysteine and risk of myocardial infarction in U.S. phisicians. Journal of American Medical Association 1992, 268: 877-881.
  • 10
    • 1842331509 scopus 로고    scopus 로고
    • Plasma homocysteine as a risk factor for vascular disease
    • The European Concerted Action Project
    • The European Concerted Action Project. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997; 277: 1775-1781.
    • (1997) JAMA , vol.277 , pp. 1775-1781
  • 11
    • 0025879850 scopus 로고
    • The prevalence of homocysteinemia and hypercolesterolemia in angiographically defined coronary artery disease
    • Ubbink JB. The prevalence of homocysteinemia and hypercolesterolemia in angiographically defined coronary artery disease. Klinishe Wochenschrift 1991; 69: 527-534.
    • (1991) Klinishe Wochenschrift , vol.69 , pp. 527-534
    • Ubbink, J.B.1
  • 13
    • 0344306693 scopus 로고    scopus 로고
    • Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium
    • Stanger O, Weger M. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Clin Chem Lab Med 2003; 41: 1444-54.
    • (2003) Clin Chem Lab Med , vol.41 , pp. 1444-1454
    • Stanger, O.1    Weger, M.2
  • 14
    • 24444472604 scopus 로고    scopus 로고
    • Homocysteine reduction-oxidation (Redox)-Receptor and regulation of extracellular matrix component in human vascular smooth muscle cells
    • Tyagi SC. Homocysteine reduction-oxidation (Redox)-Receptor and regulation of extracellular matrix component in human vascular smooth muscle cells. FASEB J 1997; 11: 3, A288.
    • (1997) FASEB J , vol.11 , Issue.3
    • Tyagi, S.C.1
  • 15
    • 0031935068 scopus 로고    scopus 로고
    • Homocysteine Redox-Receptor and regulation of extracellular matrix component in vascular cells
    • Tyagi SC. Homocysteine Redox-Receptor and regulation of extracellular matrix component in vascular cells. Am J Physiol 1998; 274: C396-C405.
    • (1998) Am J Physiol , vol.274
    • Tyagi, S.C.1
  • 16
    • 0032928601 scopus 로고    scopus 로고
    • Homocysteine and heart disease: Pathophysiology of extracellular matrix
    • Tyagi SC. Homocysteine and heart disease: pathophysiology of extracellular matrix. Clin and Exper Hypertension 1999; 21: 181-198.
    • (1999) Clin and Exper Hypertension , vol.21 , pp. 181-198
    • Tyagi, S.C.1
  • 19
    • 0035652251 scopus 로고    scopus 로고
    • Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects
    • Ventura P, Panini R, Verlato C, Scarpetta G, Salvioli G. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects. Metabolism 2001; 50: 1466-71.
    • (2001) Metabolism , vol.50 , pp. 1466-1471
    • Ventura, P.1    Panini, R.2    Verlato, C.3    Scarpetta, G.4    Salvioli, G.5
  • 20
    • 11144356292 scopus 로고    scopus 로고
    • Relations of plasma homocysteine to left ventricular structure and function: The Framingham Heart Study
    • Sundstrom J, Sullivan L, Selhub J, et al. Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. Eur Heart J 2004; 25: 523-30.
    • (2004) Eur Heart J , vol.25 , pp. 523-530
    • Sundstrom, J.1    Sullivan, L.2    Selhub, J.3
  • 21
    • 0037433466 scopus 로고    scopus 로고
    • Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction
    • Vasan RS, Beiser A, D'Agostino RB, et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA 2003; 289: 1251-1257.
    • (2003) JAMA , vol.289 , pp. 1251-1257
    • Vasan, R.S.1    Beiser, A.2    D'Agostino, R.B.3
  • 22
    • 0036889964 scopus 로고    scopus 로고
    • Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats
    • Joseph J, Washington A, Joseph L, et al. Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. Am J Physiol Heart Circ Physiol 2002; 283: H2567-74.
    • (2002) Am J Physiol Heart Circ Physiol , vol.283
    • Joseph, J.1    Washington, A.2    Joseph, L.3
  • 23
    • 2542436169 scopus 로고    scopus 로고
    • Effect of experimental hyperhomocysteinemia on cardiac structure and function in the rat
    • Walker E, Black J, Parris C, et al. Effect of experimental hyperhomocysteinemia on cardiac structure and function in the rat. Ann Clin Lab Sci 2004; 34: 175-80.
    • (2004) Ann Clin Lab Sci , vol.34 , pp. 175-180
    • Walker, E.1    Black, J.2    Parris, C.3
  • 24
    • 0037623866 scopus 로고    scopus 로고
    • Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats
    • Joseph J, Joseph L, Shekhawat NS, et al. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 2003; 285: H679-86.
    • (2003) Am J Physiol Heart Circ Physiol , vol.285
    • Joseph, J.1    Joseph, L.2    Shekhawat, N.S.3
  • 26
    • 0034127659 scopus 로고    scopus 로고
    • Myocardial matrix degradation and metalloproteinase activation in the failing heart: A potential therapeutic target
    • Spinale FG, Coker ML, Bond BR, Zellner JL. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Cardiovasc Res 2000; 46: 225-38.
    • (2000) Cardiovasc Res , vol.46 , pp. 225-238
    • Spinale, F.G.1    Coker, M.L.2    Bond, B.R.3    Zellner, J.L.4
  • 27
    • 2442457887 scopus 로고    scopus 로고
    • Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: Its inhibition as a primary effect of Angiotensinconverting enzyme inhibitor
    • Sakata Y, Yamamoto K, Mano T, et al. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensinconverting enzyme inhibitor. Circulation 2004; 109: 2143-9.
    • (2004) Circulation , vol.109 , pp. 2143-2149
    • Sakata, Y.1    Yamamoto, K.2    Mano, T.3
  • 28
    • 0034785723 scopus 로고    scopus 로고
    • Matrix metalloproteinase inhibition and the prevention of heart failure
    • Lee RT. Matrix metalloproteinase inhibition and the prevention of heart failure. Trends Cardiovasc Med 2001; 11: 202-5.
    • (2001) Trends Cardiovasc Med , vol.11 , pp. 202-205
    • Lee, R.T.1
  • 29
    • 0034885377 scopus 로고    scopus 로고
    • Matrix metalloproteinases in the progression of heart failure: Potential therapeutic implications
    • Li YY, Feldman AM. Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications. Drugs 2001; 61: 1239-52.
    • (2001) Drugs , vol.61 , pp. 1239-1252
    • Li, Y.Y.1    Feldman, A.M.2
  • 30
    • 5644304359 scopus 로고    scopus 로고
    • Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression
    • Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 2004; 44: 1609-18.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 1609-1618
    • Polyakova, V.1    Hein, S.2    Kostin, S.3    Ziegelhoeffer, T.4    Schaper, J.5
  • 31
    • 0037371849 scopus 로고    scopus 로고
    • Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation
    • Nishikawa N, Yamamoto K, Sakata Y, et al. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Cardiovasc Res 2003; 57: 766-74.
    • (2003) Cardiovasc Res , vol.57 , pp. 766-774
    • Nishikawa, N.1    Yamamoto, K.2    Sakata, Y.3
  • 32
    • 0842283185 scopus 로고    scopus 로고
    • Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure
    • Yamazaki T, Lee JD, Shimizu H, Uzui H, Ueda T. Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure. Eur J Heart Fail 2004; 6: 41-5
    • (2004) Eur J Heart Fail , vol.6 , pp. 41-45
    • Yamazaki, T.1    Lee, J.D.2    Shimizu, H.3    Uzui, H.4    Ueda, T.5
  • 33
    • 0036182632 scopus 로고    scopus 로고
    • Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats
    • Miller A, Mujumdar V, Palmer L, et al. Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens 2002; 5 (2 Pt 1): 157-63.
    • (2002) Am J Hypertens , vol.5 , Issue.2 PART 1 , pp. 157-163
    • Miller, A.1    Mujumdar, V.2    Palmer, L.3
  • 34
    • 0025095390 scopus 로고
    • Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment
    • Brattstrom L, Israelsson B, Norrving B, et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 1990; 81: 51-60. 49.
    • (1990) Atherosclerosis , vol.81 , Issue.51-60 , pp. 49
    • Brattstrom, L.1    Israelsson, B.2    Norrving, B.3
  • 35
    • 0029066299 scopus 로고
    • A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
    • Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049 -57.
    • (1995) JAMA , vol.274 , pp. 1049-1057
    • Boushey, C.J.1    Beresford, S.A.A.2    Omenn, G.S.3    Motulsky, A.G.4
  • 37
    • 0033533527 scopus 로고    scopus 로고
    • Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
    • Eikelboom JW, Lonn E, Genest J, et al. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131: 363-375.
    • (1999) Ann Intern Med , vol.131 , pp. 363-375
    • Eikelboom, J.W.1    Lonn, E.2    Genest, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.